Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Jul 6, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Exchange | Industry | Zen Rating | Market Cap | Price | 1d % | EBITDA | P/E | D/E | Country | DD Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | NASDAQ | Biotechnology | A | $11.03B | $57.50 | 0.58% | $777.43M | 20.91x | 0.23 | United States | 73 |
| PEN | PENUMBRA INC | NYSE | Medical Devices | A | $9.72B | $251.06 | 0.53% | $71.30M | 228.24x | 0.31 | United States | 51 |
| PEGA | PEGASYSTEMS INC | NASDAQ | Software - Application | A | $9.20B | $54.03 | 2.60% | $327.35M | 47.19x | 1.16 | United States | 55 |
| WIX | WIXCOM LTD | NASDAQ | Software - Infrastructure | A | $9.15B | $164.29 | -0.18% | $158.48M | 61.53x | -11.71 | Israel | 46 |
| BGC | BGC GROUP INC | NASDAQ | Capital Markets | A | $5.30B | $10.85 | 0.84% | $365.61M | 38.75x | 3.88 | United States | 41 |
| ACIW | ACI WORLDWIDE INC | NASDAQ | Software - Infrastructure | A | $4.85B | $46.21 | 1.58% | $514.57M | 17.98x | 1.16 | United States | 47 |
| PTCT | PTC THERAPEUTICS INC | NASDAQ | Biotechnology | A | $3.89B | $49.07 | -0.16% | $846.90M | 6.49x | -15.30 | United States | 35 |
| BTSG | BRIGHTSPRING HEALTH SERVICES INC | NASDAQ | Health Information Services | A | $3.85B | $22.12 | 0.55% | $468.92M | 73.73x | 2.46 | United States | 29 |
| ENS | ENERSYS | NYSE | Electrical Equipment & Parts | A | $3.54B | $90.22 | 0.27% | $558.57M | 9.86x | 1.07 | United States | 50 |
| AMRX | AMNEAL PHARMACEUTICALS INC | NASDAQ | Drug Manufacturers - Specialty & Generic | A | $2.64B | $8.42 | 0.60% | $503.18M | -210.50x | -26.56 | 25 | |
| CPRX | CATALYST PHARMACEUTICALS INC | NASDAQ | Biotechnology | A | $2.62B | $21.46 | 0.05% | $296.55M | 13.01x | 0.14 | United States | 71 |
| ARDT | ARDENT HEALTH PARTNERS INC | NYSE | Medical Care Facilities | A | $1.92B | $13.39 | -0.22% | $500.18M | 7.97x | 2.85 | United States | 52 |
| CINT | CI&T INC | NYSE | Software - Infrastructure | A | $816.90M | $6.07 | 3.23% | $96.26M | 24.28x | N/A | Cayman Islands | 37 |
| DLX | DELUXE CORP | NYSE | Advertising Agencies | A | $767.29M | $17.15 | 1.90% | $378.67M | 13.61x | 3.14 | United States | 49 |
| HRTG | HERITAGE INSURANCE HOLDINGS INC | NYSE | Insurance - Property & Casualty | A | $714.39M | $23.05 | 1.72% | $123.55M | 9.07x | 5.73 | United States | 40 |
| LYTS | LSI INDUSTRIES INC | NASDAQ | Electronic Components | A | $535.58M | $17.85 | 1.36% | $44.29M | 24.12x | 0.74 | United States | 56 |
| QUAD | QUAD/GRAPHICS INC | NYSE | Specialty Business Services | A | $294.56M | $5.82 | 1.57% | $143.30M | -16.17x | 13.26 | United States | 16 |
| MAPS | WM TECHNOLOGY INC | NASDAQ | Software - Application | A | $142.02M | $0.92 | 2.68% | $24.98M | 11.50x | 1.24 | United States | 42 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have a premium account? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.